Study of Photodynamic Therapy (PDT) Using HPPH in Barrett's Esophagus
Public ClinicalTrials.gov record NCT01236443. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase I/II Study of Photodynamic Therapy (PDT) Using 2-[1-hexyloxyethyl]-2-devinylpyropheophorbide-a (HPPH) for the Treatment of High Grade Dysplasia, Carcinoma-in-situ and Early Adenocarcinoma in Barrett's Esophagus
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
A Study to identify toxicity and optimal photodynamic treatment parameters using the photosensitizer 2-\[1-hydroxyethyl\]-2-devinylpyropheophorbide-a (HPPH) in high grade dysplasia, carcinoma-in-situ, or early adenocarcinoma in Barrett's esophagus.
Study identification
- NCT ID
- NCT01236443
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 1
- Enrollment
- 18 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jul 31, 2000
- Primary completion
- Apr 30, 2003
- Completion
- Mar 31, 2013
- Last update posted
- Jan 12, 2014
2000 – 2013
United States locations
- U.S. sites
- 1
- U.S. states
- 1
- U.S. cities
- 1
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Roswell Park cancer institute | Buffalo | New York | 14263 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Recently updated Barrett's Esophagus trials
Other public records listing Barrett's Esophagus. Sorted by last update posted; newest first. Not a recommendation.
- NCT07335445: Enhancing Screening Practices for BE Not yet recruiting
- NCT06748911: Navicam for Detection of Barrett's Esophagus Recruiting
- NCT02947971: Pilot Study for TCE Imaging of the Esophagus Using an OFDI Capsule With a Compact Imaging System Recruiting
- NCT02422433: Surveillance and Image-Guided Biopsy of the Esophagus Using an OFDI Capsule Active, not recruiting
- NCT00288119: Genetic Determinants of Barrett's Esophagus and Esophageal Adenocarcinoma Recruiting
- NCT02634645: TREAT-BE Study (Treatment With Resection and Endoscopic Ablation Techniques for Barrett's Esophagus) Recruiting
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT01236443, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jan 12, 2014 · Synced Sep 19, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT01236443 live on ClinicalTrials.gov.